Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy, Science, vol.278, issue.5341, pp.1295-1300, 1997. ,
DOI : 10.1126/science.278.5341.1295
Treatment interruptions in HIV-infected subjects, Journal of Antimicrobial Chemotherapy, vol.58, issue.3, pp.502-505, 2006. ,
DOI : 10.1093/jac/dkl268
Survival of Persons with and without HIV Infection in Denmark, 1995???2005, Annals of Internal Medicine, vol.146, issue.2, pp.87-95, 1995. ,
DOI : 10.7326/0003-4819-146-2-200701160-00003
HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity, BMJ, vol.338, issue.jan26 2, p.3172, 2009. ,
DOI : 10.1136/bmj.a3172
Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection, New England Journal of Medicine, vol.332, issue.4, pp.201-208, 1995. ,
DOI : 10.1056/NEJM199501263320401
HIV Controllers: A Homogeneous Group of HIV-1--Infected Patients with Spontaneous Control of Viral Replication, Clinical Infectious Diseases, vol.41, issue.7, pp.1053-1056, 2005. ,
DOI : 10.1086/433188
Genetic and Immunologic Heterogeneity among Persons Who Control HIV Infection in the Absence of Therapy, The Journal of Infectious Diseases, vol.197, issue.4, pp.563-571, 2008. ,
DOI : 10.1086/526786
Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long???Term Nonprogressors in the US Department of Defense HIV Natural History Study, The Journal of Infectious Diseases, vol.200, issue.11, pp.1714-1723, 2009. ,
DOI : 10.1086/646609
CD4 Dynamics over a 15 Year-Period among HIV Controllers Enrolled in the ANRS French Observatory, PLoS ONE, vol.4, issue.9, p.18726, 2011. ,
DOI : 10.1371/journal.pone.0018726.t002
URL : https://hal.archives-ouvertes.fr/pasteur-01420582
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine, Nature, vol.81, issue.7348, pp.523-527, 2011. ,
DOI : 10.1038/nature10003
Tim-3 Negatively Regulates Cytotoxicity in Exhausted CD8+ T Cells in HIV Infection, PLoS ONE, vol.8, issue.7, p.40146, 2012. ,
DOI : 10.1371/journal.pone.0040146.s002
URL : http://doi.org/10.1371/journal.pone.0040146
TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection, Nature Immunology, vol.172, issue.7, pp.691-700, 2012. ,
DOI : 10.1038/ni.2342
Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity, Blood, vol.113, issue.25, pp.6351-6360, 2009. ,
DOI : 10.1182/blood-2009-02-206557
URL : https://hal.archives-ouvertes.fr/inserm-00668485
Hepatitis C virus replication in Caucasian HIV controllers, Journal of Viral Hepatitis, vol.16, issue.1, pp.350-357, 2011. ,
DOI : 10.1111/j.1365-2893.2010.01431.x
URL : https://digital.csic.es/bitstream/10261/74972/1/accesoRestringido.pdf
Hepatitis C infection in HIV-1 natural viral suppressors, AIDS, vol.24, issue.11, pp.1689-1695, 2010. ,
DOI : 10.1097/QAD.0b013e32833a2a32
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894991
Spontaneous Control of HCV Is Associated With Expression of HLA-B*57 and Preservation of Targeted Epitopes, Gastroenterology, vol.140, issue.2, pp.686-696, 2011. ,
DOI : 10.1053/j.gastro.2010.09.042
Leukocyte Immunoglobulin-Like Receptors Maintain Unique Antigen-Presenting Properties of Circulating Myeloid Dendritic Cells in HIV-1-Infected Elite Controllers, Journal of Virology, vol.84, issue.18, pp.9463-9471, 2010. ,
DOI : 10.1128/JVI.01009-10
elite suppressors despite CTL escape mutations, The Journal of Experimental Medicine, vol.69, issue.5, pp.1357-1369, 2006. ,
DOI : 10.1089/08892220260235425
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2121215
HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, 2008. ,
Specific Phenotypic and Functional Features of Natural Killer Cells From HIV-Infected Long-Term Nonprogressors and HIV Controllers, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.53, pp.564-573, 2010. ,
DOI : 10.1097/QAI.0b013e3181d0c5b4
Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers, AIDS, vol.26, issue.15, pp.1869-1878, 2012. ,
DOI : 10.1097/QAD.0b013e32835861b0
Plasmacytoid Dendritic Cells (pDCs) From HIV Controllers Produce Interferon-?? and Differentiate Into Functional Killer pDCs Under HIV Activation, The Journal of Infectious Diseases, vol.206, issue.5, pp.790-801, 2012. ,
DOI : 10.1093/infdis/jis384
Plasmacytoid Dendritic Cells Reduce HIV Production in Elite Controllers, Journal of Virology, vol.86, issue.8, pp.4245-4252, 2012. ,
DOI : 10.1128/JVI.07114-11
URL : https://hal.archives-ouvertes.fr/hal-00669899
CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21, Journal of Clinical Investigation, vol.121, issue.4, pp.1549-1560, 2011. ,
DOI : 10.1172/JCI44539DS1
CD4+ T cells from elite suppressors are more susceptible to HIV-1 but produce fewer virions than cells from chronic progressors, Proceedings of the National Academy of Sciences, vol.184, issue.3, pp.689-698, 2011. ,
DOI : 10.1128/JVI.78.4.1718-1729.2004
Evidence for the cure of HIV infection by CCR5??32/??32 stem cell transplantation, Blood, vol.117, issue.10, pp.2791-2799, 2011. ,
DOI : 10.1182/blood-2010-09-309591
Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection, Cell, vol.86, issue.3, pp.367-377, 1996. ,
DOI : 10.1016/S0092-8674(00)80110-5
HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy, Antiviral Therapy, vol.17, issue.6, pp.1001-1009, 2012. ,
DOI : 10.3851/IMP2273
Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection, AIDS, vol.24, issue.10, pp.1598-1601, 2010. ,
DOI : 10.1097/QAD.0b013e32833b61ba
Immunovirologic Control 24 Months After Interruption of Antiretroviral Therapy Initiated Close to HIV Seroconversion, Archives of Internal Medicine, vol.172, issue.16, pp.1252-1255, 2012. ,
DOI : 10.1001/archinternmed.2012.2719
Posttreatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy. ANRS VISCONTI study, PLoS Pathog, 2013. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01420534
Immune and Viral Correlates of ???Secondary Viral Control??? after Treatment Interruption in Chronically HIV-1 Infected Patients, PLoS ONE, vol.83, issue.5, p.37792, 2012. ,
DOI : 10.1371/journal.pone.0037792.s001
Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection, Blood, vol.106, issue.10, pp.3366-3369, 2005. ,
DOI : 10.1182/blood-2005-03-1100
B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy, Blood, vol.116, issue.25, pp.5571-5579, 2010. ,
DOI : 10.1182/blood-2010-05-285528
Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes, Proceedings of the National Academy of Sciences, vol.5, issue.5, pp.3382-3387, 2000. ,
DOI : 10.1038/8400
Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection, AIDS, vol.16, issue.2, pp.189-195, 2002. ,
DOI : 10.1097/00002030-200201250-00007
Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy, AIDS, vol.15, issue.6, pp.665-673, 2001. ,
DOI : 10.1097/00002030-200104130-00001
Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication, AIDS, vol.24, issue.18, pp.2803-2808, 2010. ,
DOI : 10.1097/QAD.0b013e328340a239
Gold drug auranofin restricts the viral reservoir in the monkey AIDS model and induces containment of viral load following ART suspension, AIDS, vol.25, issue.11, pp.1347-1356, 2011. ,
DOI : 10.1097/QAD.0b013e328347bd77
Low Immune Activation despite High Levels of Pathogenic Human Immunodeficiency Virus Type 1 Results in Long-Term Asymptomatic Disease, Journal of Virology, vol.81, issue.16, pp.8838-8842, 2007. ,
DOI : 10.1128/JVI.02663-06
Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque, Journal of Clinical Investigation, vol.121, issue.6, pp.2391-2400, 2011. ,
DOI : 10.1172/JCI45235DS1
Natural SIV Hosts: Showing AIDS the Door, Science, vol.15, issue.8, pp.1188-1193, 2012. ,
DOI : 10.1038/nm.2013
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822437
Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response, Journal of Clinical Investigation, vol.119, pp.3544-3555, 2009. ,
DOI : 10.1172/JCI40093DS1
Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated 26, 1999. ,
Acute Plasma Biomarkers of T Cell Activation Set-Point Levels and of Disease Progression in HIV-1 Infection, PLoS ONE, vol.7, issue.10, 2012. ,
DOI : 10.1371/journal.pone.0046143.s007
Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders, Blood, vol.118, issue.12, pp.3263-3272, 2011. ,
DOI : 10.1182/blood-2011-01-329060
URL : http://hdl.handle.net/2434/168139
Effects of hydroxychloroquine on immune activation and disease progression among HIVinfected patients not receiving antiretroviral therapy: a randomized controlled trial, 2012. ,